Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

The Genetic Landscape of Diamond-Blackfan Anemia.

Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, Handsaker RE, Abdulhay NJ, Fiorini C, Genovese G, Lim ET, Cheng A, Cummings BB, Chao KR, Beggs AH, Genetti CA, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Vlachos A, Lipton JM, Atsidaftos E, Glader B, Narla A, Gleizes PE, O'Donohue MF, Montel-Lehry N, Amor DJ, McCarroll SA, O'Donnell-Luria AH, Gupta N, Gabriel SB, MacArthur DG, Lander ES, Lek M, Da Costa L, Nathan DG, Korostelev AA, Do R, Sankaran VG, Gazda HT.

Am J Hum Genet. 2018 Dec 6;103(6):930-947. doi: 10.1016/j.ajhg.2018.10.027. Epub 2018 Nov 29.

PMID:
30503522
2.

Investigations of urethral sphincter activity in mice with bladder hyperalgesia before and after drug administration of gabapentin.

Yeh JC, Do R, Choi H, Lin CT, Chen JJ, Zi X, Chang HH, Ghoniem G.

Int Urol Nephrol. 2018 Nov 1. doi: 10.1007/s11255-018-2021-8. [Epub ahead of print]

PMID:
30387068
3.

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, Do RK, Sun Y, Kingham TP, D'Angelica MI, Berger MF, Hyman DM, Jarnagin WR, Klimstra DS, Janjigian YY, Solit DB, Schultz N, Abou-Alfa GK.

Clin Cancer Res. 2018 Oct 29. pii: clincanres.2293.2018. doi: 10.1158/1078-0432.CCR-18-2293. [Epub ahead of print]

PMID:
30373752
4.

Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.

Harding JJ, Lowery MA, Shih AH, Schvartzman JM, Hou S, Famulare C, Patel M, Roshal M, Do RK, Zehir A, You D, Selcuklu SD, Viale A, Tallman MS, Hyman DM, Reznik E, Finley LWS, Papaemmanuil E, Tosolini A, Frattini MG, MacBeth KJ, Liu G, Fan B, Choe S, Wu B, Janjigian YY, Mellinghoff IK, Diaz LA, Levine RL, Abou-Alfa GK, Stein EM, Intlekofer AM.

Cancer Discov. 2018 Dec;8(12):1540-1547. doi: 10.1158/2159-8290.CD-18-0877. Epub 2018 Oct 24.

PMID:
30355724
5.

Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, Kono Y, Do RK, Mitchell DG, Singal AG, Tang A, Sirlin CB.

Radiology. 2018 Dec;289(3):816-830. doi: 10.1148/radiol.2018181494. Epub 2018 Sep 25.

PMID:
30251931
6.

CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.

Chakraborty J, Midya A, Gazit L, Attiyeh M, Langdon-Embry L, Allen PJ, Do RKG, Simpson AL.

Med Phys. 2018 Nov;45(11):5019-5029. doi: 10.1002/mp.13159. Epub 2018 Sep 27.

PMID:
30176047
7.

White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.

Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, Marks RM, Cruite I, Fowler KJ, Tang A, Bashir MR, Hecht EM, Kamaya A, Jambhekar K, Kamath A, Arora S, Bijan B, Ash R, Kassam Z, Chaudhry H, McGahan JP, Yacoub JH, McInnes M, Fung AW, Shanbhogue K, Lee J, Deshmukh S, Horvat N, Mitchell DG, Do RKG, Surabhi VR, Szklaruk J, Sirlin CB.

Abdom Radiol (NY). 2018 Oct;43(10):2625-2642. doi: 10.1007/s00261-018-1744-4.

PMID:
30155697
8.

Comparison of Navigator Triggering Reduced Field of View and Large Field of View Diffusion-Weighted Imaging of the Pancreas.

Mannelli L, Monti S, Corrias G, Fung MM, Nyman C, Golia Pernicka JS, Do RKG.

J Comput Assist Tomogr. 2018 Aug 16. doi: 10.1097/RCT.0000000000000778. [Epub ahead of print]

PMID:
30119065
9.

Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.

Attiyeh MA, Chakraborty J, Gazit L, Langdon-Embry L, Gonen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Do RK, Simpson AL.

HPB (Oxford). 2018 Aug 7. pii: S1365-182X(18)32703-5. doi: 10.1016/j.hpb.2018.07.016. [Epub ahead of print]

PMID:
30097414
10.

Understanding the impact of 'cost' under MACRA: a neurointerventional imperative!

Spilberg G, Nicola GN, Rosenkrantz AB, Silva Iii E, Schirmer CM, Ghoshhajra BB, Choradia N, Do R, Hirsch JA.

J Neurointerv Surg. 2018 Oct;10(10):1005-1011. doi: 10.1136/neurintsurg-2018-013972. Epub 2018 Jul 23. Review.

PMID:
30038063
11.

Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns.

Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS.

Am J Surg Pathol. 2018 Oct;42(10):1334-1345. doi: 10.1097/PAS.0000000000001118.

PMID:
30001234
12.

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies.

Harding JJ, Do RK, Dika IE, Hollywood E, Uhlitskykh K, Valentino E, Wan P, Hamilton C, Feng X, Johnston A, Bomalaski J, Li CF, O'Reilly EM, Abou-Alfa GK.

Cancer Chemother Pharmacol. 2018 Sep;82(3):429-440. doi: 10.1007/s00280-018-3635-3. Epub 2018 Jul 3.

PMID:
29971467
13.
14.

Convolutional neural networks: an overview and application in radiology.

Yamashita R, Nishio M, Do RKG, Togashi K.

Insights Imaging. 2018 Jun 22. doi: 10.1007/s13244-018-0639-9. [Epub ahead of print] Review.

15.

Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.

Creasy JM, Midya A, Chakraborty J, Adams LB, Gomes C, Gonen M, Seastedt KP, Sutton EJ, Cercek A, Kemeny NE, Shia J, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI, Do RKG, Simpson AL.

Eur Radiol. 2018 Jun 19. doi: 10.1007/s00330-018-5542-8. [Epub ahead of print]

PMID:
29922934
16.

Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging.

Perrin T, Midya A, Yamashita R, Chakraborty J, Saidon T, Jarnagin WR, Gonen M, Simpson AL, Do RKG.

Abdom Radiol (NY). 2018 Dec;43(12):3271-3278. doi: 10.1007/s00261-018-1600-6.

PMID:
29730738
17.

Face, Content, and Construct Validations of Endoscopic Needle Injection Simulator for Transurethral Bulking Agent in Treatment of Stress Urinary Incontinence.

Farhan B, Soltani T, Do R, Perez C, Choi H, Ghoniem G.

J Surg Educ. 2018 Nov;75(6):1673-1678. doi: 10.1016/j.jsurg.2018.04.011. Epub 2018 May 3.

PMID:
29730182
18.

Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.

Verbanck M, Chen CY, Neale B, Do R.

Nat Genet. 2018 May;50(5):693-698. doi: 10.1038/s41588-018-0099-7. Epub 2018 Apr 23. Erratum in: Nat Genet. 2018 Aug;50(8):1196.

19.

Rapid switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams.

Mahmood U, Horvat N, Horvat JV, Ryan D, Gao Y, Carollo G, DeOcampo R, Do RK, Katz S, Gerst S, Schmidtlein CR, Dauer L, Erdi Y, Mannelli L.

Eur J Radiol. 2018 May;102:102-108. doi: 10.1016/j.ejrad.2018.02.022. Epub 2018 Feb 19.

PMID:
29685522
20.

Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.

Nadkarni GN, Chauhan K, Verghese DA, Parikh CR, Do R, Horowitz CR, Bottinger EP, Coca SG.

Kidney Int. 2018 Jun;93(6):1409-1416. doi: 10.1016/j.kint.2018.01.026. Epub 2018 Apr 25.

PMID:
29685497
21.

Using Full Genomic Information to Predict Disease: Breaking Down the Barriers Between Complex and Mendelian Diseases.

Jordan DM, Do R.

Annu Rev Genomics Hum Genet. 2018 Aug 31;19:289-301. doi: 10.1146/annurev-genom-083117-021136. Epub 2018 Apr 11.

PMID:
29641912
22.

LI-RADS 2017: An update.

Kielar AZ, Chernyak V, Bashir MR, Do RK, Fowler KJ, Mitchell DG, Cerny M, Elsayes KM, Santillan C, Kamaya A, Kono Y, Sirlin CB, Tang A.

J Magn Reson Imaging. 2018 Jun;47(6):1459-1474. doi: 10.1002/jmri.26027. Epub 2018 Apr 6. Review.

PMID:
29626376
23.

Are Electronic and Paper Questionnaires Equivalent to Assess Patients with Overactive Bladder?

Palmer C, Farhan B, Nguyen N, Zhang L, Do R, Nguyen DV, Ghoniem G.

J Urol. 2018 Aug;200(2):369-374. doi: 10.1016/j.juro.2018.03.117. Epub 2018 Mar 30.

PMID:
29605443
24.

Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?

Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, Do RK.

Abdom Radiol (NY). 2018 Oct;43(10):2665-2672. doi: 10.1007/s00261-018-1505-4.

PMID:
29492607
25.

Influence of CT acquisition and reconstruction parameters on radiomic feature reproducibility.

Midya A, Chakraborty J, Gönen M, Do RKG, Simpson AL.

J Med Imaging (Bellingham). 2018 Jan;5(1):011020. doi: 10.1117/1.JMI.5.1.011020. Epub 2018 Feb 15.

PMID:
29487877
26.

Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.

Mier-Hicks A, Raj M, Do RK, Yu KH, Lowery MA, Varghese A, O'Reilly EM.

Clin Colorectal Cancer. 2018 Jun;17(2):121-128. doi: 10.1016/j.clcc.2018.01.008. Epub 2018 Jan 31.

PMID:
29477452
27.

Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded Cohort.

Pak LM, Chakraborty J, Gonen M, Chapman WC, Do RKG, Groot Koerkamp B, Verhoef K, Lee SY, Massani M, van der Stok EP, Simpson AL; Memorial Sloan Kettering Cancer Center Hepatopancreatobiliary Service.

J Am Coll Surg. 2018 May;226(5):835-843. doi: 10.1016/j.jamcollsurg.2018.02.001. Epub 2018 Feb 15.

PMID:
29454098
28.

Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.

Attiyeh MA, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gönen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Simpson AL, Do RK.

Ann Surg Oncol. 2018 Apr;25(4):1034-1042. doi: 10.1245/s10434-017-6323-3. Epub 2018 Jan 29.

PMID:
29380093
29.

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.

O'Reilly EM, Lee JW, Lowery MA, Capanu M, Stadler ZK, Moore MJ, Dhani N, Kindler HL, Estrella H, Maynard H, Golan T, Segal A, Salo-Mullen EE, Yu KH, Epstein AS, Segal M, Brenner R, Do RK, Chen AP, Tang LH, Kelsen DP.

Cancer. 2018 Apr 1;124(7):1374-1382. doi: 10.1002/cncr.31218. Epub 2018 Jan 16.

PMID:
29338080
30.

Imaging for pancreatic ductal adenocarcinoma.

Horvat N, Ryan DE, LaGratta MD, Shah PM, Do RK.

Chin Clin Oncol. 2017 Dec;6(6):62. doi: 10.21037/cco.2017.11.03.

31.

Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review.

Hicks AM, DeRosa A, Raj M, Do R, Yu KH, Lowery MA, Varghese A, O'Reilly EM.

Clin Colorectal Cancer. 2018 Jun;17(2):e207-e216. doi: 10.1016/j.clcc.2017.12.001. Epub 2017 Dec 12. Review.

PMID:
29306522
32.

Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.

Harding JJ, Abu-Zeinah G, Chou JF, Owen DH, Ly M, Lowery MA, Capanu M, Do R, Kemeny NE, O'Reilly EM, Saltz LB, Abou-Alfa GK.

J Natl Compr Canc Netw. 2018 Jan;16(1):50-58. doi: 10.6004/jnccn.2017.7024.

PMID:
29295881
33.

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.

Lowery MA, Kelsen DP, Capanu M, Smith SC, Lee JW, Stadler ZK, Moore MJ, Kindler HL, Golan T, Segal A, Maynard H, Hollywood E, Moynahan M, Salo-Mullen EE, Do RKG, Chen AP, Yu KH, Tang LH, O'Reilly EM.

Eur J Cancer. 2018 Jan;89:19-26. doi: 10.1016/j.ejca.2017.11.004. Epub 2017 Dec 8.

PMID:
29223478
34.

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

Chakraborty J, Langdon-Embry L, Cunanan KM, Escalon JG, Allen PJ, Lowery MA, O'Reilly EM, Gönen M, Do RG, Simpson AL.

PLoS One. 2017 Dec 7;12(12):e0188022. doi: 10.1371/journal.pone.0188022. eCollection 2017.

35.

Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma?

Pak LM, Gonen M, Seier K, Balachandran VP, D'Angelica MI, Jarnagin WR, Kingham TP, Allen PJ, Do RKG, Simpson AL.

Abdom Radiol (NY). 2018 Aug;43(8):2113-2118. doi: 10.1007/s00261-017-1407-x.

PMID:
29177926
36.

Hemodynamic effects of IV sodium nitrite in hospitalized comatose survivors of out of hospital cardiac arrest.

Dezfulian C, Olsufka M, Fly D, Scruggs S, Do R, Maynard C, Nichol G, Kim F.

Resuscitation. 2018 Jan;122:106-112. doi: 10.1016/j.resuscitation.2017.11.055. Epub 2017 Nov 23.

PMID:
29175357
37.

Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, Do RKG, Ehman EC, Fowler KJ, Hussain HK, Jha RC, Karam AR, Mamidipalli A, Marks RM, Mitchell DG, Morgan TA, Ohliger MA, Shah A, Vu KN, Sirlin CB; LI-RADS Evidence Working Group.

Radiology. 2018 Jan;286(1):29-48. doi: 10.1148/radiol.2017170554. Epub 2017 Nov 21. Review.

PMID:
29166245
38.

2017 Version of LI-RADS for CT and MR Imaging: An Update.

Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, Chernyak V, Bashir MR, Kono Y, Do RK, Mitchell DG, Kamaya A, Hecht EM, Sirlin CB.

Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098. Review.

PMID:
29131761
39.

Background, current role, and potential applications of radiogenomics.

Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA.

J Magn Reson Imaging. 2018 Mar;47(3):604-620. doi: 10.1002/jmri.25870. Epub 2017 Nov 2. Review.

PMID:
29095543
40.

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.

Zheng J, Chakraborty J, Chapman WC, Gerst S, Gonen M, Pak LM, Jarnagin WR, DeMatteo RP, Do RKG, Simpson AL; Hepatopancreatobiliary Service in the Department of Surgery of the Memorial Sloan Kettering Cancer Center; Research Staff in the Department of Surgery at Washington University School of Medicine.

J Am Coll Surg. 2017 Dec;225(6):778-788.e1. doi: 10.1016/j.jamcollsurg.2017.09.003. Epub 2017 Sep 21.

41.

Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.

Kielar A, Fowler KJ, Lewis S, Yaghmai V, Miller FH, Yarmohammadi H, Kim C, Chernyak V, Yokoo T, Meyer J, Newton I, Do RK.

Abdom Radiol (NY). 2018 Jan;43(1):218-230. doi: 10.1007/s00261-017-1281-6.

PMID:
28780679
42.

Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.

Horvat N, Nikolovski I, Long N, Gerst S, Zheng J, Pak LM, Simpson A, Zheng J, Capanu M, Jarnagin WR, Mannelli L, Do RKG.

Abdom Radiol (NY). 2018 Jan;43(1):169-178. doi: 10.1007/s00261-017-1261-x.

PMID:
28765978
43.

An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses.

Vasan N, Braghiroli MI, Shoushtari AN, Do RKG, Edelweiss M, Shamseddine A, Faraj W, Mukherji D, Haydar A, Olayan A, Sabatin F, Assi R, El Dika I, Saltz LB, Abou-Alfa GK, O'Reilly EM.

J Gastrointest Oncol. 2017 Jun;8(3):596-602. doi: 10.21037/jgo.2017.01.21. No abstract available.

44.

Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification.

Afshar M, Luk K, Do R, Dufresne L, Owens DS, Harris TB, Peloso GM, Kerr KF, Wong Q, Smith AV, Budoff MJ, Rotter JI, Cupples LA, Rich SS, Engert JC, Gudnason V, O'Donnell CJ, Post WS, Thanassoulis G; CHARGE Extracoronary Calcium Working Group.

J Am Coll Cardiol. 2017 Jun 20;69(24):2941-2948. doi: 10.1016/j.jacc.2017.04.051.

45.

O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.

Raj N, Klimstra DS, Horvat N, Zhang L, Chou JF, Capanu M, Basturk O, Do RKG, Allen PJ, Reidy-Lagunes D.

Pancreas. 2017 Jul;46(6):758-763. doi: 10.1097/MPA.0000000000000842.

46.

Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Simpson AL, Doussot A, Creasy JM, Adams LB, Allen PJ, DeMatteo RP, Gönen M, Kemeny NE, Kingham TP, Shia J, Jarnagin WR, Do RKG, D'Angelica MI.

Ann Surg Oncol. 2017 Sep;24(9):2482-2490. doi: 10.1245/s10434-017-5896-1. Epub 2017 May 30.

47.

Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.

Howson JMM, Zhao W, Barnes DR, Ho WK, Young R, Paul DS, Waite LL, Freitag DF, Fauman EB, Salfati EL, Sun BB, Eicher JD, Johnson AD, Sheu WHH, Nielsen SF, Lin WY, Surendran P, Malarstig A, Wilk JB, Tybjærg-Hansen A, Rasmussen KL, Kamstrup PR, Deloukas P, Erdmann J, Kathiresan S, Samani NJ, Schunkert H, Watkins H; CARDIoGRAMplusC4D, Do R, Rader DJ, Johnson JA, Hazen SL, Quyyumi AA, Spertus JA, Pepine CJ, Franceschini N, Justice A, Reiner AP, Buyske S, Hindorff LA, Carty CL, North KE, Kooperberg C, Boerwinkle E, Young K, Graff M, Peters U, Absher D, Hsiung CA, Lee WJ, Taylor KD, Chen YH, Lee IT, Guo X, Chung RH, Hung YJ, Rotter JI, Juang JJ, Quertermous T, Wang TD, Rasheed A, Frossard P, Alam DS, Majumder AAS, Di Angelantonio E, Chowdhury R; EPIC-CVD, Chen YI, Nordestgaard BG, Assimes TL, Danesh J, Butterworth AS, Saleheen D.

Nat Genet. 2017 Jul;49(7):1113-1119. doi: 10.1038/ng.3874. Epub 2017 May 22.

48.

Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions.

Saleheen D, Zhao W, Young R, Nelson CP, Ho W, Ferguson JF, Rasheed A, Ou K, Nurnberg ST, Bauer RC, Goel A, Do R, Stewart AFR, Hartiala J, Zhang W, Thorleifsson G, Strawbridge RJ, Sinisalo J, Kanoni S, Sedaghat S, Marouli E, Kristiansson K, Hua Zhao J, Scott R, Gauguier D, Shah SH, Smith AV, van Zuydam N, Cox AJ, Willenborg C, Kessler T, Zeng L, Province MA, Ganna A, Lind L, Pedersen NL, White CC, Joensuu A, Edi Kleber M, Hall AS, März W, Salomaa V, O'Donnell C, Ingelsson E, Feitosa MF, Erdmann J, Bowden DW, Palmer CNA, Gudnason V, Faire U, Zalloua P, Wareham N, Thompson JR, Kuulasmaa K, Dedoussis G, Perola M, Dehghan A, Chambers JC, Kooner J, Allayee H, Deloukas P, McPherson R, Stefansson K, Schunkert H, Kathiresan S, Farrall M, Marcel Frossard P, Rader DJ, Samani NJ, Reilly MP.

Circulation. 2017 Jun 13;135(24):2336-2353. doi: 10.1161/CIRCULATIONAHA.116.022069. Epub 2017 May 1.

49.

Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity.

Saleheen D, Natarajan P, Armean IM, Zhao W, Rasheed A, Khetarpal SA, Won HH, Karczewski KJ, O'Donnell-Luria AH, Samocha KE, Weisburd B, Gupta N, Zaidi M, Samuel M, Imran A, Abbas S, Majeed F, Ishaq M, Akhtar S, Trindade K, Mucksavage M, Qamar N, Zaman KS, Yaqoob Z, Saghir T, Rizvi SNH, Memon A, Hayyat Mallick N, Ishaq M, Rasheed SZ, Memon FU, Mahmood K, Ahmed N, Do R, Krauss RM, MacArthur DG, Gabriel S, Lander ES, Daly MJ, Frossard P, Danesh J, Rader DJ, Kathiresan S.

Nature. 2017 Apr 12;544(7649):235-239. doi: 10.1038/nature22034.

50.

Liver Imaging Reporting and Data System: an expert consensus statement.

Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB.

J Hepatocell Carcinoma. 2017 Feb 17;4:29-39. doi: 10.2147/JHC.S125396. eCollection 2017.

Supplemental Content

Support Center